mRNA-based – Page 8 – Communicable Diseases Research

Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers

Article

Published on 2021-08-052022-10-28
Journal: Biology [Category] COVID-19,

[키워드] adverse effects age approved AstraZeneca BTN162 vaccine carried ChAdOx1 COVID-19 vaccine chill conducted coronavirus COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines cross-sectional Cross-sectional studies demographic data drug-related side effects and adverse reactions Effect ENhance evaluate females Gender Germany Health personnel healthcare healthcare worker increased risk injection site injection site pain joint knowledge Local majority malaise methodology Moderna mRNA-1273 vaccine mRNA-based mRNA-based vaccine mRNA-based vaccines overcome Pain parameters participant Pfizer-BioNTech Prevalence questionnaire reliability reported resolved risk factor safety point side Side effect simple systemic side effect systemic side effects tested vaccination Vaccine Vaccine hesitancy Vaccines viral vector-based worker
[DOI] 10.3390/biology10080752 PMC 바로가기 [Article Type] Article

Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening

거주 노인에서 mRNA 기반 COVID-19 백신 접종 후 항체 반응: 재개방에 대한 시사점

Article

Published on 2021-08-012022-09-11
Journal: Journal of the American Medical Directors Associat [Category] SARS, 치료기술,

[키워드] adaptive Adults advanced age All participant All participants Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibody antibody level antibody levels Antibody Response assisted living B.1.1.7 Beckman Coulter blinded calculated Care coefficients collected Community condition conducted correlated correlation COVID-19 COVID-19 vaccines criteria cross-sectional Descriptive statistics detectable evaluated Factor greater IgG immune response immune responses Immunity Immunoglobulin Impact impair independent independent living Long-term care magnitude males mounted mRNA mRNA-based mRNA-based COVID-19 vaccine Multiple linear regression multiple linear regression analysis neutralization titer neutralization titers nursing homes Older older adult participant Pearson correlation personal care personal care living Pittsburgh protective effect Protective effects provide pseudovirus pseudovirus neutralization titers. Quality improvement reflex reopening response risk SARS-CoV-2 SARS-CoV-2 pseudovirus sera setting Spearman Steroids use of steroids vaccination Variation
[DOI] 10.1016/j.jamda.2021.06.006 PMC 바로가기 [Article Type] Article

Immune Assessment of BNT162b2 m-RNA-Spike Based Vaccine Response in Adults

Article

Published on 2021-07-222022-10-28
Journal: Biomedicines [Category] COVID-19,

[키워드] Activation anti-S anti-S2 antibody assessment B-specific response BNT162b2 vaccine CD134 CD25 Cell Cellular immune response circulation Clinical data doses ELISA expression flow cytometry follicular healthcare worker humoral IgG immune response immune system immunized Immunological response involved memory memory cell memory T mRNA-based of BNT162b2 peptide Peripheral blood response responses against SARS-CoV-2 SARS-CoV-2 vaccination second dose significant increases in subject subset T follicular helper cells T helper T-specific response the vaccine vaccination Vaccine vaccine efficacy Vaccines was tested were measured
[DOI] 10.3390/biomedicines9080868 PMC 바로가기 [Article Type] Article

Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data

SARS-COV-2 감염에 대한 mRNA 기반 예방 접종을 포함한 감염 관리, 직업 및 공중 보건 조치는 의료 종사자를 변형의 변형으로부터 보호하기 위해 : 감시 데이터를 사용한 14 개월 관찰 연구

Observational Study

Published on 2021-07-162022-09-10
Journal: PLoS ONE [Category] MERS, SARS, 변종, 임상,

[키워드] adjusted aerosol-generating procedure aerosol-generating procedures age Brazil calculated Canada Community community infection Coverage Cox regression declined dose effective Effectiveness evaluated finding first dose General population HCW HCWs Health healthcare healthcare worker Healthcare workers highest Infection infection control infection rate infection rates infection risk laboratory-confirmed measure Measures mRNA vaccination mRNA-based occupational health P.1 variant pandemic Precaution PROTECT provided public health public health measure reducing SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections second dose severe disease significantly surveillance data Transmissibility vaccination Vaccine vaccine dose vaccine doses variant variants variants of concern VoC widespread
[DOI] 10.1371/journal.pone.0254920 PMC 바로가기 [Article Type] Observational Study

Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience

Communication

Published on 2021-07-042022-10-28
Journal: Vaccines [Category] COVID-19,

Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines

Cardiology

Published on 2021-06-102022-10-31
Journal: Cureus [Category] COVID-19,

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Review

Published on 2021-05-062022-10-28
Journal: Vaccines [Category] COVID-19,

Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)

Communication

Published on 2021-04-252022-10-28
Journal: Viruses [Category] COVID-19, MERS, SARS,

[키워드] acute respiratory syndrome anti-SARS-CoV-2 IgG antibody Antibody Response BNT162b2 CLIA Cohort Coronavirus-2 COVID-19 dose evaluated Germany HCW healthcare worker healthy control humoral immune response Impaired individual investigated Messenger RNA mortality rate mRNA-based mRNA-based vaccine Patient Pfizer-BioNTech positive protocol recipient recipients renal Renal transplant recipients Renal transplantation response SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibody SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose significantly lower solid organ transplant SOT tested the patient the SARS-CoV-2 Transplant vaccination Vaccination strategy Vaccine vulnerable patients was determined
[DOI] 10.3390/v13050756 PMC 바로가기 [Article Type] Communication

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

Article

Published on 2021-04-162022-10-30
Journal: NPJ Vaccines [Category] COVID-19,

Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

Communication

Published on 2021-04-082022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] acute respiratory syndrome addition age anti-SARS-CoV-2 IgG antibody Antibody Response Antibody titer Antibody titers BNT162b2 boost Care Chronic kidney disease CLIA control group Coronavirus-2 correlated COVID-19 dose Effectiveness evaluated HCW healthcare worker healthy Hemodialysis humoral immune response immune immunization Infection Longitudinal data median mRNA-based mRNA-based SARS-CoV-2 vaccine mRNA-based vaccine mRNA-vaccines offer Patient Pfizer-BioNTech protective effect reactivity response SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 vaccine second dose shown significantly lower the antibody response vaccination vulnerable patients was determined
[DOI] 10.3390/vaccines9040360 PMC 바로가기 [Article Type] Communication